RADICAVA (edaravone) has fundamentally altered expectations within ALS care, presenting patients with a therapeutic approach that directly tackles disease progression rather than merely masking symptoms. This breakthrough created possibilities where limited options once existed. The subsequent introduction of RADICAVA ORS oral suspension enhanced accessibility considerably, freeing...
French 
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt